Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

U S Physical Therapy (USPH) EBITDA (2016 - 2025)

U S Physical Therapy (USPH) has disclosed EBITDA for 16 consecutive years, with -$57.4 million as the latest value for Q4 2025.

  • Quarterly EBITDA fell 70.56% to -$57.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.5 million through Dec 2025, up 29.03% year-over-year, with the annual reading at $12.5 million for FY2025, 29.02% up from the prior year.
  • EBITDA hit -$57.4 million in Q4 2025 for U S Physical Therapy, down from $25.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $25.3 million in Q3 2025 to a low of -$57.4 million in Q4 2025.
  • Historically, EBITDA has averaged $7.1 million across 5 years, with a median of $15.3 million in 2022.
  • Biggest five-year swings in EBITDA: skyrocketed 274.24% in 2021 and later crashed 1285.84% in 2024.
  • Year by year, EBITDA stood at -$42.4 million in 2021, then surged by 116.02% to $6.8 million in 2022, then tumbled by 135.77% to -$2.4 million in 2023, then plummeted by 1285.84% to -$33.7 million in 2024, then crashed by 70.56% to -$57.4 million in 2025.
  • Business Quant data shows EBITDA for USPH at -$57.4 million in Q4 2025, $25.3 million in Q3 2025, and $24.9 million in Q2 2025.